Chewing Gum for Smoking Cessation

November 22, 2025 updated by: Prof. Wang Man-Ping, The University of Hong Kong

The Effectiveness of Chewing Gum for Reducing Cigarette Consumption and Promoting Smoking Cessation: A Pilot Randomized Controlled Trial

The goal of this trial is to assess the feasibility, acceptability, and preliminary effectiveness of chewing gum to reduce cigarette consumption and promote smoking cessation. The main questions it aims to answer are: Do participants in the intervention group report a higher reduction in cigarette consumption, improved smoking cessation outcomes, and healthier oral health than the control group?

Researchers will compare chewing gum intervention to unassisted quitting to see if chewing gum works to cigarette reduction and smoking cessation.

Participants will:

  1. Receive very brief smoking cessation advice and booklet at baseline.
  2. Take chewing gum or unassisted quitting for 1 week.

Study Overview

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pokfulam
      • Hong Kong, Pokfulam, Hong Kong, 999077
        • School of Nursing, The University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Residents of Hong Kong aged 18 or above
  2. Smoking at least 1 cigarette per day over the past 3 months
  3. Have the habit of chewing gum or are willing to use chewing gum
  4. Participants who can communicate in Cantonese (including reading Chinese)
  5. Expressing an intention to quit or reduce smoking
  6. Capable of using instant messaging tools (e.g., WhatsApp, WeChat) for communication

Exclusion Criteria:

  1. Having communication barriers (either physical or cognitive)
  2. Currently participating in other smoking cessation programs or services

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Unassisted quitting
Participants in the unassisted quitting group (control group) will receive very brief smoking cessation advice (30 seconds) and a smoking cessation information booklet at baseline.
All participants will receive very brief smoking cessation advice (guided by the AWARD model, assess, warning, refer, and do-it-again) with a smoking cessation information booklet onsite at baseline.
Experimental: Chewing gum
Participants in the intervention group will receive 1-2 packs of chewing gum over a 1-week intervention period. They will also receive a leaflet of usage tips for chewing gum, including 1) the potential benefits of chewing gum, 2) suitable usage time and dosage, and 3) the proper disposal of used gum.Additionally, participants in the intervention group will receive 2-week reminder message to boost gum usage.
All participants will receive very brief smoking cessation advice (guided by the AWARD model, assess, warning, refer, and do-it-again) with a smoking cessation information booklet onsite at baseline.
Participants in the intervention group will receive 1-2 packs of chewing gum over a 1-week intervention period.
A leaflet of usage tips for chewing gum, including 1) the potential benefits of chewing gum, 2) suitable usage time and dosage, and 3) the proper disposal of used gum.
A 2-week reminder message guided by the Love and Care approach will be delivered to participants twice a week (a total of four).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Validated abstinence
Time Frame: 6-month follow-up
Biochemically validated smoking abstinence will be measured by saliva cotinine level (exhaled carbon monoxide <4 ppm and salivary cotinine <30 ng/ml)
6-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The biochemically validated smoking abstinence
Time Frame: 6-month follow-up
Smoking abstinence is defined by exhaled CO <4 ppm and salivary cotinine <30ng/ml
6-month follow-up
Number of pieces used
Time Frame: 2-week, 3-month, and 6-month follow-ups
The number of pieces used will be measured by a self-designed question: "On average, how many pieces of gum do you use every day?"
2-week, 3-month, and 6-month follow-ups
Frequency of use
Time Frame: 2-week, 3-month, and 6-month follow-ups
The frequency of use will be measured by a self-designed question: "In the past seven days, how many days have you used chewing gum?"
2-week, 3-month, and 6-month follow-ups
Duration of use
Time Frame: 2-week, 3-month, and 6-month follow-ups
Duration of use will be measured by a self-designed question: "How long do you typically use it at a time?"
2-week, 3-month, and 6-month follow-ups
Health effect
Time Frame: 2-week, 3-month, and 6-month follow-ups
Health effect will be measured by a self-designed question: "Have you noticed any changes in your oral health after using chewing gum?"
2-week, 3-month, and 6-month follow-ups
Self-reported 7-day point-prevalence abstinence
Time Frame: 2-week, 3-month, and 6-month
Smokers who did not smoke even a puff in the 7 days preceding the follow-up.
2-week, 3-month, and 6-month
Self-reported smoking change
Time Frame: 2-week, 3-month, and 6-month follow-ups
Self-reported change in number of cigarettes smoked daily of at least less 50% of the baseline number
2-week, 3-month, and 6-month follow-ups
Self-reported self-efficacy of quitting
Time Frame: 2-week, 3-month, and 6-month follow-ups
Self-reported self-efficacy of quitting includes the perception of quitting importance, difficulty, and confidence, assessing by an item scaled with 0-10, respectively. The score of zero refers to very unimportant, very easy, or very unconfident. The score of 10 refers to very important, very difficult, or very confident, respectively. Higher score refers to higher perception of quitting importance, difficulty, and confidence.
2-week, 3-month, and 6-month follow-ups
Self-reported quit attempt
Time Frame: 2-week, 3-month, and 6-month follow-ups
Self-reported quit attempt in the past 7 days.
2-week, 3-month, and 6-month follow-ups
Nicotine dependence level
Time Frame: 2-week, 3-month, and 6-month follow-ups
The nicotine dependence level will be measured by the Fagerstrom Test for Nicotine Dependence (FTND). The score ranges from 0 to 10, with higher scores indicating greater nicotine dependence.
2-week, 3-month, and 6-month follow-ups
Smoking cessation services use
Time Frame: 2-week, 3-month, and 6-month follow-ups
Using the smoking cessation service from hospitals or the government in Hong Kong
2-week, 3-month, and 6-month follow-ups
Self-reported intention to quit
Time Frame: 2-week, 3-month, and 6-month follow-ups
Self-reported intention to quit in the next days
2-week, 3-month, and 6-month follow-ups

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 11, 2025

Primary Completion (Actual)

September 26, 2025

Study Completion (Actual)

October 30, 2025

Study Registration Dates

First Submitted

January 24, 2025

First Submitted That Met QC Criteria

January 24, 2025

First Posted (Actual)

January 30, 2025

Study Record Updates

Last Update Posted (Actual)

December 1, 2025

Last Update Submitted That Met QC Criteria

November 22, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Very brief smoking cessation advice

Subscribe